Literature DB >> 35395054

Using whole-genome sequence data to examine the epidemiology of antimicrobial resistance in Escherichia coli from wild meso-mammals and environmental sources on swine farms, conservation areas, and the Grand River watershed in southern Ontario, Canada.

Nadine A Vogt1, Benjamin M Hetman1, Adam A Vogt2, David L Pearl1, Richard J Reid-Smith1,3, E Jane Parmley1, Stefanie Kadykalo3, Kim Ziebell4, Amrita Bharat5,6, Michael R Mulvey5,6, Nicol Janecko7, Nicole Ricker8, Samantha E Allen9,10, Kristin J Bondo8, Claire M Jardine8,11.   

Abstract

Antimicrobial resistance (AMR) threatens the health of humans and animals and has repeatedly been detected in wild animal species across the world. This cross-sectional study integrates whole-genome sequence data from Escherichia coli isolates with demonstrated phenotypic resistance that originated from a previous longitudinal wildlife study in southern Ontario, as well as phenotypically resistant E. coli water isolates previously collected as part of a public health surveillance program. The objective of this work was to assess for evidence of possible transmission of antimicrobial resistance determinants between wild meso-mammals, swine manure pits, and environmental sources on a broad scale in the Grand River watershed, and at a local scale-for the subset of samples collected on both swine farms and conservation areas in the previous wildlife study. Logistic regression models were used to assess potential associations between sampling source, location type (swine farm vs. conservation area), and the occurrence of select resistance genes and predicted plasmids. In total, 200 isolates from the following sources were included: water (n = 20), wildlife (n = 73), swine manure pit (n = 31), soil (n = 73), and dumpsters (n = 3). Several genes and plasmid incompatibility types were significantly more likely to be identified on swine farms compared to conservation areas. Conversely, internationally distributed sequence types (e.g., ST131), extended-spectrum beta-lactamase- and AmpC-producing E. coli were isolated in lower prevalences (<10%) and were almost exclusively identified in water sources, or in raccoon and soil isolates obtained from conservation areas. Differences in the odds of detecting resistance genes and predicted plasmids among various sources and location types suggest different primary sources for individual AMR determinants, but, broadly, our findings suggest that raccoons, skunks and opossums in this region may be exposed to AMR pollution via water and agricultural sources, as well as anthropogenic sources in conservation areas.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35395054      PMCID: PMC8993012          DOI: 10.1371/journal.pone.0266829

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

The emergence and persistence of antimicrobial resistance (AMR) is a major challenge for human health worldwide [1]. Antimicrobial resistant infections directly result in increased morbidity and mortality, and also represent a substantial burden to health care in terms of both cost and efficacy [2, 3]. There is growing evidence to suggest that wild animals play a role in acquiring and disseminating AMR determinants within the environment [4, 5]. Exploratory work, primarily in the form of cross-sectional surveys, has demonstrated that avian and mammalian wildlife may carry a variety of zoonotic agents (e.g., Salmonella, Campylobacter), some of which have been shown to be resistant to antimicrobials considered critical to human health [6-8]. In addition, bacterial clones of international importance (e.g., E. coli ST131), extended spectrum beta-lactamase-producers (ESBLs), and organisms resistant to last-resort antimicrobials (e.g., colistin, vancomycin, carbepenems) mediated by mobile resistance genes have all been isolated from and documented [9-16]. Much of the work examining the epidemiology of AMR in wildlife has been focused on wild birds [4, 17, 18]. However, there is mounting evidence that mammalian wildlife, such as raccoons (Procyon lotor), striped skunks (Mephitis mephitis), and Virginia opossums (Didelphis virginiana), can also harbour antimicrobial resistant bacteria and might therefore represent a potential source of resistant clones or AMR genes for humans and domestic animals [19-25]. With the decreasing cost of whole-genome sequencing, this technology is increasingly being used in wildlife research to simultaneously identify strains, resistance genes, plasmids, and other genetic markers, such as virulence genes, using a single laboratory processing method [26, 27]. Findings from a previous three-year longitudinal study of raccoons and environmental samples in southern Ontario demonstrated that the overall prevalence of AMR among untyped Escherichia coli isolates from raccoon fecal samples did not differ significantly between swine farms and conservation areas [19]. However, a comparison of resistance phenotypes and genotypes (determined using PCR) of the resistant E. coli isolates in these different location types revealed similar phenotypes and resistance genes among isolates obtained in conservation areas that were altogether absent from isolates obtained on swine farms (e.g., blaCMY-2) [19], suggesting that there may, indeed, be differences in the types of AMR determinants carried by raccoons, depending on the local environment. Our recent epidemiologic assessment of the subset of Salmonella and E. coli isolates originating from swine farms using genomic data revealed frequent overlap, and thus, possible transmission, of AMR determinants between soil and raccoons, but there was limited overlap between isolates from raccoons and swine manure pits [28]. The aim of the present work was to build on the previous longitudinal study [19], and small-scale analysis of genomic data from swine farm isolates [28], by incorporating additional whole-genome sequencing data from E. coli isolates obtained in conservation areas, to explore the potential impact of different location types (swine farms vs. conservation areas) on the occurrence of AMR determinants in raccoons. In addition, we sought to examine phenotypically resistant E. coli water isolates obtained by routine public health surveillance in the same study region and time period alongside the isolates from the previous wildlife study, to better understand the potential role of raccoons and other meso-mammals in the ecology of AMR in a broader context. Thus, our specific objectives were: 1) to assess for evidence of possible transmission of AMR determinants between wildlife, swine manure pits, and environmental sources at a broad scale in the Grand River watershed, and 2) to assess for evidence of possible transmission of AMR determinants at a local scale, for the subset of wildlife and environmental samples collected in different location types (swine farms vs. conservation areas). Possible transmission of E. coli and AMR determinants between different sampling sources was assessed using population structure assessments, and epidemiological modeling of select AMR determinants (i.e., genes, predicted plasmids). The aim of our epidemiological modeling was to infer potential transmission based on the distribution patterns of AMR determinants (determined in silico), by assessing the impact of source type and location type (if applicable) on the occurrence of select genes and plasmid incompatibility (Inc) groups. An additional objective was to assess the validity of in silico identification of AMR genes, using phenotypic susceptibility test results as the gold standard.

Methods

Dataset

Escherichia coli isolates examined within this study were obtained from samples collected previously for two different projects/programs. Isolates from wildlife, swine manure pits, and environmental samples, excluding water, were obtained from a previous longitudinal wildlife study on swine farms and conservation areas in southern Ontario (2011–2013) [19, 22]. This previous wildlife study was approved by the Animal Care Committee at the University of Guelph following the guidelines of the Canadian Committee on Animal Care (Permit number: 11R015). Water-derived isolates, collected in the same geographic region and time period as the longitudinal study, were obtained through the FoodNet Canada surveillance program. The study region was located within the Grand River watershed (6800km2), and the surrounding region, which includes Guelph, Kitchener, Waterloo and Cambridge, is a populous region of southern Ontario (~1 million people) that overlaps with intensive agricultural operations and an abundance of natural ecosystems (12 conservation areas; ~19,400 hectares).

Wildlife, swine manure pit, dumpster, and soil E. coli isolates

Selection of E. coli isolates for sequencing from the previous wildlife study was based on demonstrated phenotypic resistance to at least one of 15 antimicrobials (see details below), as previously reported by Bondo et al. [19]. Samples from this previous wildlife study included: paw wipes and fecal swabs from live-trapped raccoons, striped skunks, and Virginia opossums, soil samples, swine manure pit samples (from swine farms only), and dumpster wipes (from conservation areas only). Live trapping was focused on raccoons; however, skunks and opossums that were successfully trapped were also sampled [22]. Methods used to trap and process wildlife have been previously described by Bondo et al. [19]. In 2012 only, the paws of captured wildlife were also sampled to assess for surface transmission of microorganisms [29]. Methods used to obtain soil, swine manure pit, and dumpster samples are also available in Bondo et al. [19]. In 2011, three E. coli isolates were cultured from each sample; for samples with more than one isolate demonstrating phenotypic resistance, selection of one resistant isolate for sequencing was performed using a random number generator. A total of 203 isolates were available for sequencing from the following sources: dumpster (n = 3), swine manure pit (n = 31), raccoon fecal (n = 53), raccoon paw (n = 16), soil (n = 93), skunk fecal (n = 4), skunk paw (n = 1), opossum fecal (n = 2).

FoodNet Canada water-derived E. coli isolates

Phenotypically resistant E. coli isolates from water samples obtained as part of the FoodNet Canada surveillance program were included in the present study if they were collected in the Region of Waterloo sentinel site; sampling of water for generic E. coli in this region was initiated in 2012 and continued through 2013. Water sampling was performed bi-weekly at five core water sites in the Grand River watershed, and three recreational areas in the study region; one of these sites was a conservation area that was also sampled in the wildlife study. Further details regarding water sampling, including a map and description of sites, is available from Kadykalo et al. [30]. A total of 20 sequenced isolates from water samples were available for inclusion in this study.

Previous culture and susceptibility testing

Isolation and susceptibility testing of untyped E. coli from water samples and the samples from the previous wildlife study were performed as previously described [19, 30, 31]. Susceptibility to 15 antimicrobials was determined using an automated microbroth dilution system (Sensititre, Thermo Scientific) with the National Antimicrobial Resistance Monitoring System (NARMS) antimicrobial test panel CMV3AGNF: azithromycin (AZM), gentamicin (GEN), kanamycin (KAN), streptomycin (STR), amoxicillin-clavulanic acid (AMC), cefoxitin (FOX), ceftiofur (TIO), ceftriaxone (CRO), ampicillin (AMP), chloramphenicol (CHL), sulfisoxazole (SOX), trimethoprim-sulfamethoxazole (SXT), tetracycline (TCY), nalidixic acid (NAL), and ciprofloxacin (CIP). Isolates with only intermediate resistance were considered susceptible, both in selection for sequencing and for interpretation alongside in silico resistance results.

DNA extraction, whole-genome sequencing and genome assembly

Genomic DNA extractions were performed at the University of Guelph, or at the National Microbiology Laboratory (NML) in Winnipeg, Manitoba. Briefly, cultures of 2 ml broth cultures of E. coli were grown overnight, and 1 ml was used in the Qiagen DNEasy plant and tissue 96 kit, using manufacturer protocols (Qiagen, Hilden, Germany). DNA extracts were sequenced at the NML in Guelph, Ontario or at the NML in Winnipeg, Manitoba using Nextera XT libraries and Illumina MiSeq version 3 or NextSeq550 platforms according to manufacturer protocols. Raw reads were assembled using SPAdes [32], as part of the Shovill pipeline (version 1.0.1; https://github.com/tseeman/shovill) with the following settings: "—minlen 200—mincov 2;—assembler spades;—trim".

Analysis of whole-genome assemblies

Prediction of legacy multi-locus sequence types was performed using MLST (version 2.19.0; https://github.com/tseemann/mlst), which uses the 7-loci Achtman scheme (https://pubmlst.org/mlst/). Core-genome multi-locus sequence typing (cgMLST) of isolates was performed using the ‘fairly simple allele calling’ tool fsac (version 1.2.0; https://github.com/dorbarker/fsac) and the 2513-loci Enterobase scheme (https://enterobase.warwick.ac.uk/). Isolates with 30 or more missing loci were considered poor quality and were excluded from any further analyses. Minimum spanning trees generated by the standalone GrapeTree software package (version 1.5) [33] were used to visualize population structure, using the "MSTreeV2" algorithm. A cluster threshold of k = 50 was used for all visualizations. This lenient clustering threshold was selected to provide a general, qualitative assessment of overlap between isolates from different sources, since the threshold of k = 10 is used by PulseNet as a starting point to consider isolates as potentially belonging to the same strain [34]. Identification of acquired resistance genes was performed using Abricate (version 0.8.13; https://github.com/tseemann/abricate) and the Resfinder database (updated May–17 2020); settings used were 90% identity and 60% coverage. For the identification of acquired beta-lactamases, the identity and coverage settings were increased to 100% identity and 90% coverage. Sensitivity and specificity of in silico AMR prediction were calculated for each antimicrobial class, and overall (i.e., all individual test results pooled); phenotypic test results were considered as the gold standard, and resistance was considered a positive test result. Test sensitivity and specificity were not assessed for drug classes for which chromosomal mutations are responsible for a considerable proportion of expressed resistance (i.e., quinolones) [35]. As a quality control measure, isolates with missing genotypes for resistant phenotypic test results for three or more of the seven antimicrobial classes assessed were examined and excluded from further analyses if the number of missing cgMLST loci exceeded 20. Plasmid Inc types were identified using Abricate (version 0.8.13; https://github.com/tseemann/abricate) and the Plasmidfinder database (updated May–17 2020). Settings used were 98% identity and 70% coverage. Serotyping was performed using ECTyper (version 1.0.0, database version 1.0; https://github.com/phac-nml/ecoli_serotyping) with default settings.

Statistical analyses

Multi-level logistic regression was used to model the odds of select plasmid Inc types and AMR genes found in E. coli from different sources. All statistical tests were performed using STATA (STATA Intercooled 14.2; StataCorp, College Station, Texas, USA). Only Inc types and resistance genes present in at least 10% and less than 90% of isolates were modeled statistically. In addition to examination of the overall dataset (A), analyses were also performed for a subset of the data (B) consisting of soil and wildlife isolates collected from conservation areas and swine farms (Fig 1). Source type was examined as an independent variable for both datasets (A) and (B), and the categorization of sampling sources for each dataset is provided in Fig 1. For the subset of data (B), location type (swine farm vs. conservation area) was also examined as an independent variable for sources replicated in both location types (i.e., soil and wildlife isolates). For the full dataset (A), we did not evaluate location type as an independent variable since water isolates originated from a variety of location types across the watershed that could not be characterized by a single group distinct from swine farms and conservation areas. A causal diagram illustrating the relationships between the different variables is provided in Fig 2. The mixed logistic regression models included random intercepts to account for clustering at the site-level, and at the level of the individual sampling source (i.e., animal, swine manure pit, dumpster). Models that did not converge using the ‘melogit’ command were fitted using ‘meqrlogit’, which uses QR decomposition methods. Sampling year was included in these mixed models if it confounded the association between source or location type (i.e., its addition caused a >20% change in the coefficient of those variables) [36], or if it was statistically significant (p ≤ 0.05). Model fit was assessed by examining the best linear unbiased predictions for normality and homoscedasticity, and Pearson’s residuals were examined for potential outliers. If variance components were very small (<1x10-3), the Bayesian Information Criterion (BIC) value was used to compare the fit of the multi-level logistic regression model to an ordinary logistic regression, and the better fitting model was reported [36]. All tests were two-tailed, and a significance level of α = 0.05 was used for all analyses.
Fig 1

Classification of source types for overall dataset (A), and subset of data (B), with sample sizes and independent variables analysed of Escherichia coli isolates collected in southern Ontario, 2011−2013.

Fig 2

Causal diagram illustrating the relationships between source type, location type, year of sampling, and the carriage of predicted plasmids and antimicrobial resistance genes in Escherichia coli isolates collected from wildlife, swine manure pits, and environmental sources in southern Ontario, 2011−2013.

Solid lines show directionality of proposed relationships between dependent and independent variables. Dashed grey lines show potential confounding relationships.

Classification of source types for overall dataset (A), and subset of data (B), with sample sizes and independent variables analysed of Escherichia coli isolates collected in southern Ontario, 2011−2013.

Causal diagram illustrating the relationships between source type, location type, year of sampling, and the carriage of predicted plasmids and antimicrobial resistance genes in Escherichia coli isolates collected from wildlife, swine manure pits, and environmental sources in southern Ontario, 2011−2013.

Solid lines show directionality of proposed relationships between dependent and independent variables. Dashed grey lines show potential confounding relationships.

Results

Description of dataset

A total of 223 sequenced isolates were available for inclusion. Following exclusion based on 30 or greater missing loci with the 2513-loci cgMLST scheme, 200 isolates with the following source distribution were available for subsequent analyses: water (n = 20), swine manure pit (n = 31), wildlife (n = 73), and other environmental sources (n = 76; 73 soil isolates, 3 dumpster isolates). Accession numbers for isolates from the previous wildlife study are available in S1 File. Wildlife isolates originated from 58 unique raccoons, two opossums, and four skunks. In several cases, isolates were obtained from the same animal captured on different occasions; two isolates from one skunk, two isolates from five different raccoons, and four isolates from one raccoon. For the subset of isolates (B) collected from the same source type on both swine farms and conservation areas (i.e., wildlife and soil, n = 146), the following distribution was noted in conservation areas: wildlife (n = 46; 31 raccoon fecal, 12 raccoon paw, 2 opossum fecal, 1 skunk fecal), and soil (n = 28). For the subset of isolates collected on swine farms (n = 103), the distribution was as follows: swine manure pit (n = 31), soil (n = 45), and wildlife (n = 27; 20 raccoon fecal, 3 raccoon paw, 3 skunk fecal, 1 skunk paw). Isolates were obtained from a total of 15 sites in the Grand River watershed: five swine farms, six conservation areas, and four river sites in the region. Isolates were roughly evenly distributed across different years (2011, n = 63; 2012, n = 58; 2013, n = 79), but for isolates collected from water, the majority were collected in 2013 (n = 17/20), and the remaining three isolates were obtained in 2012.

Distribution of serotypes and MLST types

In total, 113 serovars representing 94 sequence types were identified. Eight isolates were not typeable by MLST (1 water, 2 manure, 1 dumpster, 1 skunk, 1 raccoon, 2 soil), due to a missing allele or a partial match, and 1 isolate could not be serotyped. Serovars consistent with pathogenic E. coli strains (e.g., Shiga-toxin producing strains) and sequence types of international importance were identified [37], among which several isolates also demonstrated AMR. Based on identified serotypes, two non-O157 E. coli isolates were identified: one O103:H21 ST2354 isolate with phenotypic resistance to streptomycin from a skunk, and one O103:H2 ST2307 isolate with phenotypic resistance to ampicillin, sulfisoxazole, and trimethoprim/sulfamethoxazole from a soil isolate. A number of water, soil and wildlife E. coli isolates were also identified as internationally important sequence types responsible for causing urinary tract and bloodstream infections in humans (ST69, ST95, and ST131) [37]; most of these isolates were identified in the Grand River (upstream of the drinking water intake), and in conservation area 1 (Table 1). In addition to ST131, other major sequences types associated with uropathogenic E. coli (UPEC) strains were identified in raccoons in conservation areas: fourteen ST10 isolates, and two ST127 isolates [38]. Apart from ST10, none of the isolates from swine manure pits contained these major sequence types (ST69, ST73, ST95, ST96, ST127, ST131 or ST140). A summary of the sequence types and serovars identified are available in S1 and S2 Tables.
Table 1

Distribution of Escherichia coli sequence types of international importance identified in phenotypically resistant isolates collected from wildlife and environmental sources in southern Ontario, Canada 2011−2013 (n = 200).

NCBI Accession NumberIsolate IdSequence TypeSerotypeSource TypeResistance PatternbResistance GenesPlasmid Incompatibility Group(s)Location TypeLocation Id
- - ST69 O77/O17/O44/O106:H19WaterNALNone identifiedIncB/O/K/ZGrand River, drinking water intake13
- - O77/O17/O44/O106/O73:H18WaterAMP-AZM-CIP-NAL-STR-SOX-TCY-SXTaph(3”)-Ib, aph(6)-Id, dfra14, mphA, sul2, tet(B), blaTEM-1Col156, IncFIA(HI1), IncFIA, IncFII(pRSB107), IncYGrand River, drinking water intake13
- - O25:H4WaterKAN-STR-SOX-TCYtet(B), blaTEM-1Col156, IncFIB(AP001918)Grand River, drinking water intake13
- - O25:H4WaterAMP-NAL-TCYtet(B), blaTEM-1Col156, IncFIB(AP001918)Grand River, drinking water intake13
- - O25:H4WaterAMP-NAL-TCYtet(B), blaTEM-1IncB/O/K/Z, IncFIB(AP001918)Grand River, drinking water intake13
JAIUVT000000000N18-00294O77/O17/O44/O106/O73:H18Raccoon fecalAMP-TCYtet(A), blaTEM-1IncFII, IncFIB(AP001918)Conservation area4
JAIUUZ000000000N18-00347O77/O17/O44/O106:H18Raccoon fecalAMP-KAN-STR-SOX-TCYaph(3”)-Ib, aph(3’)-Ia, aph(6)-Id, sul2, tet(B), blaTEM-1IncFIA, IncFIB(AP001918)Conservation area1
JAIUUI000000000N18-00377O77/O17/O44/O106:H18Raccoon pawAMP-TCYtet(A), blaTEM-1IncFII, IncFIB(AP001918)Conservation area5
JAIUUV000000000N18-00354 ST95 O25:H4Raccoon pawCHL-SOX-SXTaadA2, ant(3”)-Ia, cmlA1, dfrA12, mefB, sul3IncFIB(AP001918)Conservation area1
JAIUSZ000000000N18-04249 ST131 O25:H4Raccoon fecalCIP-NAL-TCYtet(A), blaTEM-1IncFIA, IncFIIConservation area1
JAIUVI000000000N18-00331O25:H4SoilAMP-TCYtet(A), blaTEM-1IncFII, IncFIB(AP001918)Conservation area1

a No sequence types of international importance were identified in swine manure pit isolates.

b AMP = ampicillin; CHL = chloramphenicol; CRO = ceftriaxone; FOX = cefoxitin; SOX = sulfisoxazole; STR = streptomycin; SXT = trimethoprim sulfamethoxazole; TCY = tetracycline; NAL = nalidixic acid; CIP = ciprofloxacin.; KAN = kanamycin.

a No sequence types of international importance were identified in swine manure pit isolates. b AMP = ampicillin; CHL = chloramphenicol; CRO = ceftriaxone; FOX = cefoxitin; SOX = sulfisoxazole; STR = streptomycin; SXT = trimethoprim sulfamethoxazole; TCY = tetracycline; NAL = nalidixic acid; CIP = ciprofloxacin.; KAN = kanamycin.

Population structure based on cgMLST

The population structure of E. coli for the overall dataset (A), and for subset (B) are presented in Figs 3 and 4, respectively. Similar or identical E. coli subtypes were identified from diverse sources (Figs 3A, 4A), regardless of the location type (for wildlife and soil isolates; Fig 4B), or the degree of AMR (Figs 3B, 4C).
Fig 3

Population structure of 200 Escherichia coli isolates (dataset A) from wildlife, swine manure pits, and environmental sources in southern Ontario based on 2513-loci cgMLST scheme from Enterobase.

Minimum spanning tree created using k = 50 clustering threshold in GrapeTree. (A) Distribution of source types. (B) Antimicrobial resistance by number of drug classes. Frequency counts are in square brackets. Bubble size is proportional to the number of isolates in each cluster, and each cluster contains isolates differing at a maximum of 50 cgMLST loci.

Fig 4

Population structure of 146 Escherichia coli isolates (dataset B) from wildlife and soil on swine farms and conservation areas in southern Ontario based on 2513-loci cgLMST scheme from Enterobase.

Minimum spanning tree created using k = 50 clustering threshold in GrapeTree. (A) Distribution of sources. (B) Distribution by location type. (C) Antimicrobial resistance by number of drug classes. Frequency counts are in square brackets. Bubble size is proportional to the number of isolates in each cluster, and each cluster contains isolates differing at a maximum of 50 cgMLST loci.

Population structure of 200 Escherichia coli isolates (dataset A) from wildlife, swine manure pits, and environmental sources in southern Ontario based on 2513-loci cgMLST scheme from Enterobase.

Minimum spanning tree created using k = 50 clustering threshold in GrapeTree. (A) Distribution of source types. (B) Antimicrobial resistance by number of drug classes. Frequency counts are in square brackets. Bubble size is proportional to the number of isolates in each cluster, and each cluster contains isolates differing at a maximum of 50 cgMLST loci.

Population structure of 146 Escherichia coli isolates (dataset B) from wildlife and soil on swine farms and conservation areas in southern Ontario based on 2513-loci cgLMST scheme from Enterobase.

Minimum spanning tree created using k = 50 clustering threshold in GrapeTree. (A) Distribution of sources. (B) Distribution by location type. (C) Antimicrobial resistance by number of drug classes. Frequency counts are in square brackets. Bubble size is proportional to the number of isolates in each cluster, and each cluster contains isolates differing at a maximum of 50 cgMLST loci.

In silico determination of AMR genes and plasmid Inc types

In total, 43 resistance genes and 28 plasmid Inc groups were identified (Tables 2 and 3, S3 Table). The most commonly identified resistance genes, with >10% overall prevalence were: blaTEM-1, tet(A), tet(B), sul1, sul2, aph(6)-Id, ant(3”)-Ia, aph(3”)-Ib (Table 2). Three plasmid types were identified with a >10% overall prevalence: IncFIB(001918), IncI1(1-alpha), and IncFII (Table 3). Resistance genes of human health importance were also identified (e.g., AmpC-producers, ESBLs); ten E. coli isolates contained blaCMY-2, and one raccoon E. coli isolate contained a blaTEM-35. Of the isolates containing blaCMY-2, two were multi-drug resistant (MDR; 3+ antimicrobial classes) isolates collected from raccoons, and all but two of these isolates were obtained from raccoons captured in conservation areas. One of the two MDR E. coli isolates from raccoons had the phenotypic resistance pattern AMC-AMP-FOX-TIO-CRO-CHL-GEN-NAL-STR-SOX-TCY and intermediate resistance to CIP and contained resistance genes aac(3)-IVa, ant(3”)-Ia, aph(3”)-Ib, aph(6)-Id, floR, sul1, sul2, and tet(A) in addition to blaCMY-2; this particular isolate also contained two plasmid Inc types, IncC and IncFIBAP001918. The other MDR E. coli isolate from a raccoon on a swine farm was resistant to AMC-AMP-FOX-TIO-CRO-CHL-STR-SOX-TCY-SXT, and, in addition to blaCMY-2, contained genes aadA2, aph(3”)-Ib, dfrA12, floR, sul1, sul2, tet(A), and an IncC plasmid. An E. coli water isolate from the Grand River was identified with a blaOXA-1; this isolate demonstrated phenotypic resistance to AMP-CHL-STR-SOX-TCY, as well as intermediate resistance to AMC, and contained genes ant(3”)-Ia, aph(3”)-Ib, aph(6)-Id, floR, tet(A), tet(B), and an IncX1-1 plasmid. Genes conferring quinolone resistance were also identified: qnrS1 was identified in an isolate from a raccoon captured in a conservation area with IncI1(1-alpha) and IncX1-1 plasmids, and a qnrB19 gene was identified in a water isolate that displayed phenotypic resistance to AMP-CHL-GEN-STR-SOX-TCY-SXT and intermediate resistance to CIP, and also contained genes aac(3)-IId, aadA5, aph(3”)-Ib, aph(6)-Id, catA1, dfrA1, sul2, blaTEM-1, and an IncFIBAP001918 plasmid. Other resistance genes such as blaCARB-2 and catA1 were identified in less than five isolates in the wildlife subset and were found only in isolates obtained from conservation areas.
Table 2

Frequencies of acquired antimicrobial resistance genes identified using whole-genome sequence data from phenotypically resistant Escherichia coli isolates from wildlife, swine manure pits, and environmental sources in southern Ontario, Canada 2011−2013 (n = 200).

Antimicrobial GroupResistance GeneAccession No.Wildlifea (n = 73)Swine Manure Pit (n = 31)Water (n = 20)Other Environmentalb (n = 76)Total (%)
Aminoglycoside aac(3)-IId EU02231430115 (2.5%)
aac(3)-IVa NC_00983840138 (4.0%)
aadA2 JQ36496741139 (4.5%)
aadA5 AF13736160118 (4.0%)
ant(3’’)-Ia X0234011731435 (17.5%)
aph(3’)-Ia V00359/EF015636503412 (6.0%)
aph(3’)-IIa V0061801001 (0.5%)
aph(3")-Ib AF321551/AF0246022413112977 (38.5%)
aph(4)-Ia V0149900101 (0.5%)
aph(6)-Ic X0170201001 (0.5%)
aph(6)-Id M288292413112977 (38.5%)
Beta-lactam bla CMY-2 X91840701210 (5.0%)
bla TEM-1 AY458016/ HM749966/ FJ560503287111763 (31.5%)
bla TEM-35 KP86098610001 (0.5%)
bla CARB-2 M6905800011 (0.5%)
bla OXA-1 HQ17051000101 (0.5%)
Lincosamide lnuC AY92818000011 (0.5%)
lnuF EU11811900011 (0.5%)
Macrolide mphA U3657830104 (2.0%)
mphB D8589200101 (0.5%)
mef(B) FJ19638510012 (1.0%)
ereA DQ15775200011 (0.5%)
Folate pathway inhibitors dfrA1 AF203818/ X0092621159 (4.5%)
dfrA5 X1286811349 (4.5%)
dfrA8 U1018610001 (0.5%)
drfA12 AM04070830014 (2.0%)
dfrA14 DQ38812330159 (4.5%)
dfrA16 AF17412900011 (0.5%)
dfrA17 FJ46023860118 (4.0%)
dfrA23 AJ74636110001 (0.5%)
sul1 EU7800131421825 (12.5%)
sul2 HQ840942/ AY034138181101645 (22.5%)
sul3 AJ45941831138 (4.0%)
Phenicol floR AF118107712414 (7.0%)
catA1 V0062220204 (2.0%)
cmlA1 M6455621126 (3.0%)
Quinolone QnrB19 EU43227700101 (0.5%)
QnrS1 AB18751510001 (0.5%)
Fosfomycin fosA7 LAPJ0100001410034 (2.0%)
Tetracycline tet(A) AF534183301153783 (41.5%)
tet(B) AF326777/ AP0003421916101964 (32.0%)
tet(C) AY046276/ AF05534500033 (1.5%)
tetM X0438800011 (0.5%)

Values from Resfinder database.

a Includes fecal isolates from raccoons (n = 51), skunks (n = 4), opossums (n = 2), and paw swab samples from raccoons (n = 14), and one skunk.

b Includes soil (n = 73) and dumpster isolates (n = 3).

Table 3

Frequencies of plasmid incompatibility (Inc) types identified using whole-genome sequence data from phenotypically resistant Escherichia isolates obtained from wildlife, swine manure pits, and environmental sources in southern Ontario, Canada, 2011−2013 (n = 200).

Inc typeTotal (n)(% of 200)
IncFIB(AP001918)79(39.5%)
IncI1(alpha)32(16.0%)
IncFII29(14.5%)
IncFIA19(9.5%)
p011119(9.5%)
IncY17(8.5%)
IncX1-112(6.0%)
IncQ114(7.0%)
Col15610(5.0%)

a Inc types identified in fewer than 10 isolates included: IncR (n = 9), IncFIA(HI1) (n = 6), IncFIC(FII) (n = 5), IncFIB(K) (n = 4), IncFII(29), (n = 4), IncHI2A (n = 3), IncHI2 (n = 3), IncA/C2 (n = 3), IncB/O/K/Z (n = 2), IncFII(pHN7A8) (n = 2), ColBS512 (n = 2), ColE10 (n = 2), ColpVC (n = 2), IncFIB(pB171) (n = 1), ColIMGS31 (n = 1), IncFII(pRSB107) (n = 1), IncHI1A(CIT) (n = 1), IncHI1B(CIT) (n = 1), IncX1-4 (n = 1).

Values from Resfinder database. a Includes fecal isolates from raccoons (n = 51), skunks (n = 4), opossums (n = 2), and paw swab samples from raccoons (n = 14), and one skunk. b Includes soil (n = 73) and dumpster isolates (n = 3). a Inc types identified in fewer than 10 isolates included: IncR (n = 9), IncFIA(HI1) (n = 6), IncFIC(FII) (n = 5), IncFIB(K) (n = 4), IncFII(29), (n = 4), IncHI2A (n = 3), IncHI2 (n = 3), IncA/C2 (n = 3), IncB/O/K/Z (n = 2), IncFII(pHN7A8) (n = 2), ColBS512 (n = 2), ColE10 (n = 2), ColpVC (n = 2), IncFIB(pB171) (n = 1), ColIMGS31 (n = 1), IncFII(pRSB107) (n = 1), IncHI1A(CIT) (n = 1), IncHI1B(CIT) (n = 1), IncX1-4 (n = 1).

Sensitivity and specificity of in silico AMR prediction

The overall sensitivity and specificity of in silico identification of resistance genes were 95.9% and 95.5%, respectively (Table 4). Test sensitivity and specificity were at least 95% for all drug classes, except for test sensitivity of beta-lactams (90.2%), and test specificity of aminoglycosides (81.8%).
Table 4

Test sensitivity and specificitya for in silico identification of antimicrobial resistance genes in Escherichia coli isolates from wildlife, swine manure pits, and environmental sources in southern Ontario, 2011–2013 (n = 200).

Antimicrobial classTest Sensitivity (95%CI)Test Specificity (95%CI)
Aminoglycoside95.5% (89−99%)81.8% (73−88%)
Beta-lactam90.2% (82−96%)98.3% (94−99%)
Macrolide100% (16−100%)97.0% (93−99%)
Sulfonamide97.0% (90−97%)97.0% (92−99%)
Phenicol95.6% (78−99%)99.4% (97−99%)
Tetracycline98.6% (95−99%)96.2% (87−99%)
Overall b 95.9% (9398%)95.5% (9497%)

a Phenotypic antimicrobial resistance test results were considered the gold standard. Detection of 15 antimicrobials performed using the CMV3AGNF panel from National Antimicrobial Resistance Monitoring System (Sensititre, Thermo Scientific). In silico acquired resistance genes detected using Abricate and the Resfinder database.

b Raw counts for all isolates and antimicrobials were pooled together.

a Phenotypic antimicrobial resistance test results were considered the gold standard. Detection of 15 antimicrobials performed using the CMV3AGNF panel from National Antimicrobial Resistance Monitoring System (Sensititre, Thermo Scientific). In silico acquired resistance genes detected using Abricate and the Resfinder database. b Raw counts for all isolates and antimicrobials were pooled together.

Associations between source type, location type and the carriage of resistance genes and plasmid Inc types

Genes tet(B), blaTEM-1, and sul2 were significantly associated with source type in the overall dataset (Table 5). The odds of identifying tet(B) were significantly greater for swine manure pit isolates compared to isolates from wildlife and other environmental sources, but there were no significant differences between other sources (Tables 5 and 6). The odds of identifying sul2 were greater in isolates from water compared to all other sources, and they were significantly greater in isolates from wildlife and other environmental sources compared to swine manure pit isolates (Tables 5 and 6). The odds of identifying blaTEM-1 were significantly greater in water isolates compared to swine manure and other environmental isolates, and higher in wildlife compared to other environmental isolates (Tables 5 and 6). No associations with source type were identified for the remaining genes and plasmid Inc types examined (Table 5). Among statistically significant models in dataset (A), clustering by sampling site was noted for both the tet(B) and blaTEM-1 models, and model assumptions were met.
Table 5

Logistic regression modelsa,b,c assessing the association between source type and the occurrence of select plasmid incompatibility types and antimicrobial resistance genes in phenotypically resistant Escherichia coli isolates collected from wildlife, swine manure pits, and environmental sources in southern Ontario, 2011−2013 (n = 200, dataset A).

tet(A) a tet(B) b , c bla TEM-1 b sul1 b
Source type OR (95%CI) p-value OR (95%CI) p-value OR (95%CI) p-value OR (95%CI) p-value
Swine manure pitREF 0.216 (global) REF 0.021 (global) REF 0.029 (global) REF 0.161 (global)
Water0.61 (0.17−2.19)0.4330.92 (0.26−3.19)0.8924.03 (1.01−16.18)0.0500.72 (0.05−9.63)0.805
Wildlife1.27 (0.53−3.03)0.5930.28 (0.11−0.74)0.0102.11 (0.74−6.01)0.1613.76 (0.75−18.84)0.107
Other environmentald1.72 (0.73−4.09)0.2150.32 (0.13−0.79)0.0130.88 (0.31−2.54)0.8151.75 (0.34−9.05)0.504
sul2 a ant(3”)-Ia a aph(3”)-Ib b aph(6)-Id b
Source type OR (95%CI) p-value OR (95%CI) p-value OR (95%CI) p-value OR (95%CI) p-value
Swine manure pitREF <0.001 (global) REF 0.810 (global) REF 0.379 (global) REF 0.379 (global)
Water30.00 (3.40−264.50)0.0020.60 (0.14−2.68)0.5081.85 (0.51−6.66)0.3471.85 (0.51−6.66)0.347
Wildlife9.82 (1.25−77.20)0.0300.61 (0.21−1.75)0.3570.73 (0.28−1.91)0.5180.73 (0.28−1.91)0.518
Other environmentald8.00 (1.01−63.23)0.0490.77 (0.28−2.15)0.6240.91 (0.36−2.32)0.8470.91 (0.36−2.32)0.847
IncFIB(AP001918) a IncI1(1-alpha) b , e IncFII a
Source type OR (95%CI) p-value OR (95%CI) p-value OR (95%CI) p-value
Swine manure pitREF 0.186 (global) REF 0.594 (global) REF 0.425 (global)
Water2.80 (0.83−9.49)0.0970.23 (0.01−4.40)0.3310.86 (0.21−3.41)0.827
Wildlife2.39 (0.91−6.26)0.0761.39 (0.28−7.00)0.6890.42 (0.14−1.29)0.130
Other environmentald2.63 (1.01−6.85)0.0471.09 (0.22−5.39)0.9170.52 (0.18−1.52)0.232

a The random intercept to account for clustering by site or animal was not retained in the model, thus ordinary logistic regression was used.

b Included a random intercept for clustering by site. Variance components were: tet(B) 0.10 (95%CI: 0.00−4.12); blaTEM-1 0.24 (95%CI: 0.03−1.80); sul1 0.27 (95%CI: 0.02−3.12); aph(3’’)-Ib 0.05 (95%CI: 0.00−28.92); aph(6)-Id 0.05 (95%CI: 0.00−28.92); IncI1(1-alpha) 0.93 (95%CI: 0.13−6.49).

c Adjusted for confounding by year of sampling

d Includes soil and dumpster isolates.

e A random intercept to account for clustering of isolates obtained from the same animal/dumpster/manure pit was retained in this model (variance components 0.54, 95%CI: 0.00−301.89).

Table 6

Contrasts from logistic regression modelsa,b,c (Table 5) assessing the statistically significant associations between source type and the occurrence of select antimicrobial resistance genes in phenotypically resistant Escherichia coli isolates collected from wildlife, swine manure pits, and environmental sources in southern Ontario, 2011−2013 (n = 200, dataset A).

tet(B) a , b bla TEM-1 b sul2 c
ContrastOR (95%CI)p-valueOR (95%CI)p-valueOR (95%CI)p-value
Water vs. wildlife3.23 (0.99−10.52)0.0511.91 (0.59−6.16)0.2803.05 (1.09−8.52)0.033
Other environmentald vs. wildlife1.12 (0.51−2.48)0.7720.42 (0.19−0.90)0.0250.81 (0.38−1.75)0.600
Other environmentald vs. water0.35 (0.11−1.09)0.0710.22 (0.06−0.73)0.0140.27 (0.09−0.75)0.012

a Adjusted for confounding by year of sampling.

b Site of sampling was retained as a random intercept.

c The random intercept to account for clustering by site or animal was not retained in the model, thus ordinary logistic regression was used.

d Includes soil and dumpster isolates.

a The random intercept to account for clustering by site or animal was not retained in the model, thus ordinary logistic regression was used. b Included a random intercept for clustering by site. Variance components were: tet(B) 0.10 (95%CI: 0.00−4.12); blaTEM-1 0.24 (95%CI: 0.03−1.80); sul1 0.27 (95%CI: 0.02−3.12); aph(3’’)-Ib 0.05 (95%CI: 0.00−28.92); aph(6)-Id 0.05 (95%CI: 0.00−28.92); IncI1(1-alpha) 0.93 (95%CI: 0.13−6.49). c Adjusted for confounding by year of sampling d Includes soil and dumpster isolates. e A random intercept to account for clustering of isolates obtained from the same animal/dumpster/manure pit was retained in this model (variance components 0.54, 95%CI: 0.00−301.89). a Adjusted for confounding by year of sampling. b Site of sampling was retained as a random intercept. c The random intercept to account for clustering by site or animal was not retained in the model, thus ordinary logistic regression was used. d Includes soil and dumpster isolates. In the subset (B) of isolates that were collected in both location types, only blaTEM-1 was significantly associated with source, with the odds of identifying this gene being significantly greater in isolates from wildlife compared to those from soil, and sampling site was retained as a random intercept for this model (Table 7). The following genes and plasmid types had a significantly greater odds of identification in isolates collected on swine farms compared with conservation areas: plasmid type IncFIB(AP001918), aph(3”)-Ib, tet(A), and aph(6)-Id (Table 6). Plasmid types IncFII, and IncI1(1-alpha), and genes ant(3”)-Ia, sul1, sul2, and tet(B) were not associated with either source type or location type (Table 7). All model assumptions were met.
Table 7

Logistic regression models,, assessing the association between source type, location type, and the occurrence of select plasmid incompatibility types and antimicrobial resistance genes in phenotypically resistant Escherichia coli isolates from wildlife and soil samples collected on swine farms and conservation areas in southern Ontario, 2011−2013 (n = 146, dataset B).

Independent variable Sub-category tet(A) tet(B) bla TEM-1
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
Location type Conservation areaREF0.031a (global)REF0.331b (global)REF0.437b (global)
Swine farm2.06 (1.06−4.01)0.0331.64 (0.60−4.44)0.3310.69 (0.26−1.77)0.438
Source type SoilREF0.698b (global)REF0.938b (global)REF0.029b,c (global)
Wildlife0.88 (0.44−1.76)0.7160.97 (0.45−2.08)0.9383.13 (1.35−7.22)0.008
sul1 sul2 ant(3”)-Ia
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
Location type Conservation areaREF0.998a (global)REF0.914a (global)REF0.333a (global)
Swine farm1.0 (0.29−3.50)0.9980.96 (0.44−2.08)0.9141.54 (0.64−3.75)0.336
Source type SoilREF0.151a (global)REF0.553a (global)REF0.655a (global)
Wildlife2.07 (0.77−5.57)0.1511.27 (0.58−2.76)0.5530.82 (0.34−1.97)0.655
aph(3”)-Ib aph(6)-Id IncFIB(AP001918)
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
Location type Conservation areaREF0.011a (global)REF0.011a (global)REF0.031a (global)
Swine farm2.45 (1.22−4.92)0.0122.45 (1.22−4.92)0.0122.07 (1.06−4.04)0.032
Source type SoilREF0.492b (global)REF0.492b (global)REF0.738a (global)
Wildlife0.78 (0.38−1.60)0.4920.78 (0.38−1.60)0.4920.89 (0.46−1.72)0.738
IncI1(1-alpha) IncFII
OR (95% CI) p-value OR (95% CI) p-value
Location type Conservation areaREF0.203b (global)REF0.571b (global)
Swine farm0.39 (0.09−1.66)0.2031.33 (0.49−3.59)0.573
Source type SoilREF0.516b (global)REF0.614a (global)
Wildlife1.36 (0.54−3.43)0.5160.77 (0.29−2.09)0.615

a The random intercept for clustering by site or animal was not retained in the model, thus ordinary logistic regression was used.

b Included a random intercept for clustering at the site-level. Variance components were: tet(A) source type 0.22 (95%CI: 0.03−1.72); tet(B) source type 0.13 (95%CI: 0.00−4.63); tet(B) location type 0.16 (95%CI: 0.00−2.91); blaTEM-1 location type 0.22 (95%CI: 0.02−2.33); blaTEM-1 source type 0.24 (95% CI: 0.02−2.40); sul1 location type 0.40 (95%CI: 0.05−3.39); sul1 source type 0.41 (95%CI: 0.05−3.36); aph(3”)-Ib source type 0.32 (95%CI: 0.02−3.50); aph(6)-Id source type 0.32 (95%CI: 0.02−3.50); IncI1(1-alpha) source type 0.73 (95%CI: 0.11−4.69); IncI1(1-alpha) location type 0.63 (95%CI: 0.10−3.95).

c Adjusted for confounding by year of sampling.

a The random intercept for clustering by site or animal was not retained in the model, thus ordinary logistic regression was used. b Included a random intercept for clustering at the site-level. Variance components were: tet(A) source type 0.22 (95%CI: 0.03−1.72); tet(B) source type 0.13 (95%CI: 0.00−4.63); tet(B) location type 0.16 (95%CI: 0.00−2.91); blaTEM-1 location type 0.22 (95%CI: 0.02−2.33); blaTEM-1 source type 0.24 (95% CI: 0.02−2.40); sul1 location type 0.40 (95%CI: 0.05−3.39); sul1 source type 0.41 (95%CI: 0.05−3.36); aph(3”)-Ib source type 0.32 (95%CI: 0.02−3.50); aph(6)-Id source type 0.32 (95%CI: 0.02−3.50); IncI1(1-alpha) source type 0.73 (95%CI: 0.11−4.69); IncI1(1-alpha) location type 0.63 (95%CI: 0.10−3.95). c Adjusted for confounding by year of sampling.

Discussion

Previous work examining the role of wildlife in the maintenance and transmission of AMR has often, but not always, shown that wild animals living in close proximity to humans are more likely to carry organisms displaying resistance [23, 27, 39–42]. It is apparent that regional approaches are most useful in understanding complex ecological issues such as the movement of AMR between different sources. Selection of isolates for this study was based on previously demonstrated phenotypic resistance, and, although biased, this work provides insights about the nature of AMR transmission between different wildlife, livestock, and environmental sources in the Grand River watershed. The majority of E. coli isolates in this study originated from raccoons and soil (~70%), followed by swine manure pits and water isolates, with very few isolates from additional sources (i.e., dumpsters, skunks, opossums). In part, this distribution was related to sampling methods of previous work (e.g., fewer samples were obtained from swine manure pits than from raccoons; see Bondo et al. [19]). Interestingly, the number of resistant E. coli obtained from wildlife and soil samples in the previous wildlife study was nearly identical between conservation areas (n = 74) and swine farms (n = 72), and the overall prevalence of resistant E. coli among raccoon fecal samples did not significantly differ by location type [19]. With location type as a proxy for the impact of the local environment (i.e., farm vs. conservation area) on the occurrence of AMR determinants in wildlife isolates, it appeared that the presence of AMR determinants in general does not vary within this region, regardless of proximity to agriculture. Our present analysis of population structure suggests that mixing of isolates from different sources and location types is frequently occurring, with no obvious clustering of E. coli cgMLST subtypes by either of these factors, or by the presence of AMR. However, along with previous findings of distinct resistance patterns and AMR genes between swine farms and conservation areas [19], our examination of resistance genes, predicted plasmids, and internationally important sequence types offers a more nuanced picture of the distribution and potential movement of AMR within this study population. A diversity of AMR genes and plasmid Inc types were identified in our study, some of which varied significantly depending on the sampling source and location type. Although most genes and plasmid Inc groups could not be modeled due to their low overall prevalence (<5%), several of the more prevalent resistant genes (e.g., tet(A), tet(B), blaTEM-1) and Inc groups (e.g., IncFIB[AP001918]) occurred in at least 30% of all isolates. Our results provide evidence of the complexity of AMR movement and transmission, in that the factors influencing the occurrence of each resistance determinant were variable. Several overarching patterns emerged, however. For instance, the presence of resistance genes sul2, and blaTEM-1 were consistently higher in water-derived isolates compared to all other sources, possibly related to upstream wastewater treatment plants along the Grand River [43]. Conversely, for resistance determinants that were analyzed by location type (i.e., wildlife and soil isolates from swine farms or conservation areas), the odds of identifying many of these genes and predicted plasmids were significantly greater in swine farm environments compared to conservation areas, regardless of sampling source, which suggests that agriculture may be the primary source of these particular AMR genes and plasmids for wildlife in our study. Combining findings from the overall dataset with the subset analysis of wildlife and soil isolates provides some additional clues about potential primary sources and the movement of certain resistance genes. Tetracycline genes tet(A) and tet(B), for instance, demonstrated contrasting epidemiological patterns; the odds of an isolate carrying tet(A) were significantly greater on swine farms than in conservation areas for the wildlife and soil isolates examined, but this gene was not associated with swine manure pits, or any other particular source overall. By contrast, the odds of identifying tet(B) were no different between swine farms and conservation areas, but the odds of this gene were significantly greater in water and swine manure isolates compared to those from wildlife, and other environmental samples. Thus, for certain resistance determinants such as tet(A), it appears that the local environment may act as an important predictor of their distribution in wildlife. Conversely, the distribution of other genes such as tet(B) appears to be vary with the sampling source, rather than the local environment. However, keeping in mind the extensive nature of this particular watershed and the convergence of many different waterways, the difference between farm environments and conservation areas in this region that share broadly similar geographic characteristics may not, in fact, be sufficiently different to influence the distribution of certain genes and plasmids (e.g., tet(B)). A strikingly similar pattern of these two tetracycline resistance genes was also documented in wild small mammals (i.e., mice, voles, shrews) captured in the same study region in 2008; tet(A)–but not tet(B)–was significantly more likely to be identified in animals captured on swine farms compared to residential areas [39]. When we previously examined the epidemiology of these two genes among E. coli in the swine farm environment in detail, no clear patterns emerged by farm location, year of sampling, or source (raccoons, soil, swine manure pits) [28]. Antimicrobial use data for these swine farms were unavailable, but tetracyclines are often used in the Canadian swine industry [44]. The impact of naturally occurring tetracycline resistance in the soil is unknown in this context, and merits further consideration in future work examining the distribution of AMR in wildlife in different types of environments [45]. The only resistance determinant that was consistently associated with source type for both the overall dataset, and for the wildlife subset, was blaTEM-1; moderate clustering by sampling site was also consistently noted for this gene (for both datasets). With the odds of identifying blaTEM-1 being significantly higher in water and wildlife, and with clustering by site regardless of location type, this suggests an anthropogenic, wildlife, or environmental source besides the swine farms sampled in this study. In the future, multivariable modelling, along with larger sample sizes, particularly for certain sources that were under-sampled in our study (e.g., dumpsters), may help clarify the importance of these sources, and other wildlife, in the occurrence and distribution of AMR genes. Although year of sampling was not consistently a confounder in our models, this factor merits consideration in future work, as the patterns and distributions of resistance genes might be expected to gradually change over longer periods of time, and this possibility should not be ruled out based on lack of significance in our three-year study. In addition to a handful of serovars representing potentially pathogenic serotypes (e.g., O103), E. coli isolates representing major sequence types commonly associated with human bloodstream and urinary tract infections were also identified in raccoon, water, and soil isolates (e.g., ST69, ST131, ST95) [37], and many of these isolates also displayed MDR. The vast majority of these particular raccoon and soil isolates were identified in conservation area 1 (n = 4/6 isolates), despite uniform sampling of raccoons and soil across 10 sampling sites in the previous wildlife study [19]. Of particular note, a ciprofloxacin-resistant E. coli ST131 isolate was identified in a raccoon from conservation area 1; fluoroquinolone-resistant E. coli ST131 are widely recognized as a major cause of community and hospital-acquired urinary tract infections in humans across the world [46]. Apart from typical outdoor recreational activities enjoyed by visitors to conservation area 1, there was no apparent source of contamination (e.g., sewage, landfills) in the general vicinity which would account for these findings of major sequence types concentrated at this particular site. Although these isolates could not be analyzed statistically due to their low overall prevalence, their appearance exclusively in water sources and conservation areas suggests that agriculture is not a major risk factor for these strains. That said, indirect exposure to agricultural sources via water run-off cannot be ruled out, given the widespread presence of agriculture in this watershed, and the numerous waterways which feed into water sources within these conservation areas. Our findings of human-associated sequence types, AmpC-producers, and genes conferring resistance to quinolones among raccoon and soil samples strictly from conservation areas, are consistent with previous epidemiological findings by Bondo et al. [19], who demonstrated that resistant E. coli were significantly more likely to be detected on the paws of raccoons in conservation areas compared to swine farms, and suggested this might be related to raccoons foraging human garbage in those locations. Our findings are also in line with recent work by Worsley-Tonks et al. [23] which provides further evidence that proximity to anthropogenic sources can influence the carriage of AMR by raccoons. In their Chicago-based study, urban raccoons trapped near wastewater treatment plants had a greater likelihood of carrying plasmid-associated resistance genes compared to those sampled on sites without such sources of AMR contamination nearby [23]. Related work comparing E. coli in raccoons and domestic dogs in urban parks in Chicago revealed that exchange of extended-spectrum cephalosporin-resistant E. coli may be occurring between these two species (based on a single-nucleotide polymorphism analysis), but dogs are not likely to be a major source of these organisms for urban raccoons, since the prevalence of these resistant E. coli was significantly lower in dogs compared to raccoons (16.5% vs. 56.9%, respectively) [24]. Given the opportunistic foraging nature of raccoons, numerous routes of transmission may plausibly contribute to the acquisition of AMR determinants by these animals from human sources in conservation areas, including human refuse, dog refuse, littered garbage, or dumpsters [19].

Limitations

The selection of isolates based on demonstrated phenotypic resistance contributes to a biased representation of certain outcomes; for instance, the prevalence of pathogenic E. coli among the isolates included in our study should not necessarily be considered as representative of the population of untyped E. coli obtained in the previous wildlife study [19]. Any outcomes presented in this work must therefore be interpreted as being within the population of resistant E. coli from these sampling sources. Knowing that the prevalence of resistant E. coli varied considerably between different sources (57% of swine manure isolates; 22% of water isolates; 14% of dumpster isolates; 6−7% of raccoon paw and fecal isolates; 10% of soil isolates), the measures of association reported within our study should not be interpreted literally as the precise odds of identifying a certain gene or plasmid in one source compared to another. Instead, our analyses are targeted at addressing where certain AMR determinants are most concentrated within this population of resistant E. coli, in order to postulate primary sources, and to identify evidence of potential transmission between sources. Using cross-sectional data to address these research questions has inherent limitations, particularly for determining transmission, and, by extension, the direction of transfer. A number of methodological limitations also merit consideration. The prediction of AMR genes using in silico tools generally appears to be highly sensitive and specific, similar to other work [47, 48] and our previous assessment [28]. Comparison of the performance of in silico tools between different studies should be done cautiously, however, since test performance depends on more than the particular in silico AMR identification tool used: the identity and coverage cut-offs used (where applicable), the quality of sequencing data, and other aspects of bioinformatics pipelines (e.g., quality control) are all potential factors which can impact test results. In addition, we did not assess AMR prediction of a major drug class (quinolones), since the focus on this work was acquired resistance genes, and not chromosomal resistance mechanisms. Although all MDR isolates were positive for plasmid Inc groups that have previously been associated with the resistance genes identified, further confirmation that these genes were in fact contained within the plasmid rather than on the chromosome, is needed. Without the use of selective media, certain pathogenic E. coli serovars identified here may be underrepresented (i.e., non-O157 verotoxigenic E. coli; VTEC), and the presumed virulence of potentially pathogenic strains (based on serovar) requires further confirmation in future investigations to facilitate comparison to other recent surveys of raccoons that have demonstrated these animals may shed VTEC and enteropathogenic E. coli (EPEC) in their feces [25]. Finally, the inclusion of location type as a predictor in our hypothesis-generating study may need to be revisited in future work, since the characterization of agricultural sources in the ecosystem is undoubtedly more complex than what we have suggested here, and the contribution of upstream agricultural sources that were not directly sampled within our study were not accounted for in our analyses. Consequently, a lack of association with location type in our study should therefore not be taken to mean that agriculture is not an important risk factor for certain resistance genes and plasmids in this region.

Conclusions

Recognizing that regional approaches are needed to better understand complex issues such as AMR which affects all components of the ecosystem, our cross-sectional study addresses knowledge gaps regarding the distribution and potential transmission of resistance genes and predicted plasmids in a southern Ontario ecosystem. Using isolates obtained from wildlife, swine manure pits, and environmental sources, this work contributes to a more comprehensive examination of the role of wildlife in the maintenance and transmission of AMR determinants within the Grand River watershed. While some resistance genes were associated with certain sources (i.e., blaTEM-1 in water and wildlife), others were associated with certain location types (i.e., aph(3”)-Ib, tet(A), and aph(6)-Id were higher on swine farms than conservation areas). Meanwhile, major sequence types frequently implicated in human illness (i.e., ST69, ST131, ST95) were found exclusively in isolates from water, and in raccoon and soil-derived isolates on conservation areas, but not on swine farms. In combination with previous work on this raccoon population demonstrating that AmpC-producing E. coli were almost exclusively identified in conservation areas, these findings are suggestive of anthropogenic sources for these particular types of resistance determinants. Overall, the variability in the distribution of different cgMLST subtypes, sequence types, genes, and plasmid Inc groups by source and location type underscores the complex set of factors and interactions which can influence the distribution of various determinants of resistance. Based on our findings, it is clear that apparently healthy wildlife may act as sentinels and sources of AMR contamination and potentially pathogenic E. coli for humans, and that some may differ in their carriage of certain sequence types, genes, and plasmids according to their local environment. Future investigations focused on intervention-based approaches, integration of antimicrobial use data on farms, sampling of additional livestock sources, and use of whole-genome sequence data to confirm plasmid structure and associated genes would help to address certain major knowledge gaps in this field.

Gene accession numbers for Escherichia coli isolates from previous wildlife study.

(XLSX) Click here for additional data file.

Multi-locus sequence types identified using whole-genome sequence data of phenotypically resistant Escherichia coli isolates obtained from wildlife, swine manure pits, and environmental sources in southern Ontario, Canada, 2011−2013.

(DOCX) Click here for additional data file.

Serotypes identified using whole-genome sequence data of phenotypically resistant Escherichia coli isolates obtained from wildlife, swine manure pits, and environmental sources in southern Ontario, Canada, 2011−2013.

(DOCX) Click here for additional data file.

Distribution of plasmid incompatibility types identified using whole-genome sequence data by source type for phenotypically resistant Escherichia coli isolates from wildlife, swine manure pits, and environmental sources in southern Ontario, Canada, 2011−2013.

(DOCX) Click here for additional data file. 16 Feb 2022
PONE-D-21-40450
Using whole-genome sequence data to examine the epidemiology of antimicrobial resistance in Escherichia coli from wild meso-mammals and environmental sources on swine farms, conservation areas, and the Grand River watershed in southern Ontario
PLOS ONE Dear Dr. Vogt, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please address all questions raised and provide clarifications based on reviewer comments. Please submit your revised manuscript by Apr 02 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Iddya Karunasagar Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. Additional Editor Comments: The reviewers have pointed out number of aspects of the manuscript that need clarifications and revision. Please address all comments point by point. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Using whole-genome sequence data to examine the epidemiology of antimicrobial resistance in Escherichia coli from wild meso-mammals and environmental sources on swine farms, conservation areas, and the Grand River watershed in southern Ontario Manuscript Number: PONE-D-21-40450 The study derived the whole-genome sequence data of Escherichia coli isolates with demonstrated antibiotic resistance phenotypes. The isolates belonged to a previous wildlife study and a public health surveillance program. In total, 200 isolates from water, wildlife, swine manure pit, and other environmental samples such as soil and dumpsters were used. The AMR genes corresponding to antibiotic resistance phenotypes were identified insilico. Plasmid incompatibility groups were also identified, more frequently among swine isolates. Although the study does not precisely identify the sources of AMR strains, certain conclusions were drawn on the frequency of occurrence of AMR strains and the genotypes, likely transfer of resistance or the acquisition of AMR genes by E. coli isolates associated with small mammals. 1. Comments: The study relies heavily on statistical analysis for arriving at definite conclusions at the end. The MDR isolates belonging to sequence types of public health significance were isolated from a limited number of small mammals. The isolates were collected during 2011-13. Wouldn’t the resistance patterns or the distribution of E. coli have changed in these regions over the years? This is also obvious from the relatively low prevalence of MDR phenotypes and the distribution of plasmid-borne genes (e.g. β-lactamase genes) among the isolates. 2. The procedures for sample collection, treatment and isolation E. coli have already been published for these isolates. Therefore, this section can be significantly shortened (L133-161). Similarly, I guess L175-194 also refer to the procedures followed in 2011. 3. The study used whole genome sequence data of a large number of isolates (n=200). However, the distribution of isolates from different sources vary widely, with most of the isolates belonging to raccoons and soil. This might have impacted the statistical analysis, since the distribution or the odds of finding a resistance gene can vary widely when the number of isolates is not uniform. 4. The rate and frequency of isolation of pathogenic E. coli (e.g. STEC) strains depend on the special selective enrichment regimes used for their isolation. Since no such protocols have been used for the isolation of human pathogenic E. coli groups in this study, the identified serogroups might represent only a proportion of such isolates from different sources. 5. Further, there other sources of pathogenic E. coli strains such as the feces of other small animals, birds etc. Specific E. coli pathogroups are also found associated with swine. Therefore, E. coli isolates from the paw of raccoons may not simply represent “contaminants form external sources such as water or anthropogenic sources”. 6. L298-300: E. coli serovars (including O103) can often be associated with human, animal or avian sources. I agree with the authors that this serotype has caused human infections, but isn’t there a possibility that such strains can be associated naturally with the wild animals? 7. Based on the statistical analysis, the chances of finding tet(B) were higher among swine manure isolates, those of blaTEM-1 and sul2I genes were higher among isolates from water. Are there any specific reasons for this association? Are certain antibiotics employed in these swine farms? 8. In L491 it is said that tet(A) is not associated with any particular source overall. However, the following paragraph (L495-495) suggests that the tet(A) genes might have originated from the swine farms. Similarly, since tet(B) gene is more prevalent in water isolates, water was presumed to be the source of this gene in all other environments. These are contradictory. When this gene is uniformly found across different environments, how is its source and mode of dissemination predicted? Studies have shown tet genes in bacteria from pristine areas that were never exposed to antibiotics. 9. In L589-591, it is stated that small animals are at higher risk of acquiring AMR E. coil through anthropogenic contamination. L80-81 suggest small mammals could be a potential source of AMR to humans and domestic animals. 10. Lines 532-533: “Resistant E. coli were significantly more likely to be detected on the paws of raccoons in conservation areas compared to swine farms”. Why is it so? 11. The manuscript emphasizes on pathogenic and resistant E. coli strains being found on the paws of raccoons. However, there is always a possibility of such strains being associated with the gastrointestinal tracts of healthy raccoons. A recent study [ Orden et al., 2020. Raccoons (Procyon lotor) in the Madrid region of Spain are carriers of antimicrobial-resistant Escherichia coli and enteropathogenic E. coli. Zoonoses Public Health. 2021; 68: 69– 78] have reported the presence of pathogenic and AMR E. coli in the feces of small mammals like raccoons and suggest these as the sources of such strains to humans. Certain serovars (e.g. O77, O25) were found both on raccoon paws and faeces in your study too. Reviewer #2: The work presented in this article contributes to a comprehensive examination of the role of wild life in the maintenance and dissemination of AMR determinants within the Grand River watershed. The work is particularly important to identify the circulation of antimicrobial resistance genes and the mobile genetic elements that facilitate their transmission among different sources including humans. Authors could successfully relate the association of some of the antimicrobial resistance determinants to a particular environment or location types. However, the authors have not discussed or analyzed the association of phenotypic resistance and the occurrence of corresponding drug resistance genes among different sources. Comments 1. Authors have used a significant amount of data from their previous study, this causes repetition of data. 2. Number of samples used from each source is not clearly mentioned in the methodology ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. 23 Feb 2022 We thank reviewers for their thoughtful comments and suggestions that have helped to improve the manuscript. Our comments are below. Lines numbers correspond to the tracked changes version. Reviewer #1: Using whole-genome sequence data to examine the epidemiology of antimicrobial resistance in Escherichia coli from wild meso-mammals and environmental sources on swine farms, conservation areas, and the Grand River watershed in southern Ontario Manuscript Number: PONE-D-21-40450 The study derived the whole-genome sequence data of Escherichia coli isolates with demonstrated antibiotic resistance phenotypes. The isolates belonged to a previous wildlife study and a public health surveillance program. In total, 200 isolates from water, wildlife, swine manure pit, and other environmental samples such as soil and dumpsters were used. The AMR genes corresponding to antibiotic resistance phenotypes were identified in silico. Plasmid incompatibility groups were also identified, more frequently among swine isolates. Although the study does not precisely identify the sources of AMR strains, certain conclusions were drawn on the frequency of occurrence of AMR strains and the genotypes, likely transfer of resistance or the acquisition of AMR genes by E. coli isolates associated with small mammals. 1. Comments: The study relies heavily on statistical analysis for arriving at definite conclusions at the end. The MDR isolates belonging to sequence types of public health significance were isolated from a limited number of small mammals. The isolates were collected during 2011-13. Wouldn’t the resistance patterns or the distribution of E. coli have changed in these regions over the years? This is also obvious from the relatively low prevalence of MDR phenotypes and the distribution of plasmid-borne genes (e.g. β-lactamase genes) among the isolates. Thank you for the feedback. It's true that we lean heavily on our statistical analysis for interpretation, since we used an epidemiological approach to explore the frequencies, patterns and distributions of resistance genes and plasmid replicons in different sources, and location types. We agree that the resistance patterns or distribution of E. coli may have changed in these regions over the years, thus, we opted to account for year as a potential confounder in our analyses (see Figure 2). We've added a line in the discussion to convey the point you make (lines 610-613). 2. The procedures for sample collection, treatment and isolation E. coli have already been published for these isolates. Therefore, this section can be significantly shortened (L133-161). Similarly, I guess L175-194 also refer to the procedures followed in 2011. Thank you for pointing this out, these sections have been shortened, and only the most important details have been retained (lines 155-211). 3. The study used whole genome sequence data of a large number of isolates (n=200). However, the distribution of isolates from different sources vary widely, with most of the isolates belonging to raccoons and soil. This might have impacted the statistical analysis, since the distribution or the odds of finding a resistance gene can vary widely when the number of isolates is not uniform. It's true that unbalanced data can be problematic and cause modeling issues. In our analyses, we opted to reclassify sources into larger groups (Fig 1) to ensure adequate statistical power, and more balanced sampling of categories. We ended up with the distribution shown in Table 2 for our source type analyses: wildlife (n=73), swine manure pit (n=31), water (n=20), and "other environmental" (n=76). For the subset analysis on swine farms and conservation areas, the source distribution ended up being even: wildlife (n=73), soil (n=73). We report all 95% confidence intervals around our OR estimates to ensure it's clear to the reader that certain categories which are smaller have wider confidence intervals. Although the source distributions for the broad analysis are not ideal, our study represents a hypothesis-generating study, and we were opportunistic with available data from available sources, and careful to focus only on one variable at a time, either "location type" or "source type" (while accounting for potential confounding effects of sampling year). In line with the suggestions above, we have suggested larger sample sizes of certain source categories are needed in future work (lines 607-610). 4. The rate and frequency of isolation of pathogenic E. coli (e.g. STEC) strains depend on the special selective enrichment regimes used for their isolation. Since no such protocols have been used for the isolation of human pathogenic E. coli groups in this study, the identified serogroups might represent only a proportion of such isolates from different sources. Thank you for pointing out this limitation. It has been added to the manuscript (lines 680-682). 5. Further, there other sources of pathogenic E. coli strains such as the feces of other small animals, birds etc. Specific E. coli pathogroups are also found associated with swine. Therefore, E. coli isolates from the paw of raccoons may not simply represent “contaminants form external sources such as water or anthropogenic sources”. We have ensured that we have qualified our discussions of pathogenic E. coli strains with the word "potential" (lines 713-714; line 682) and maintain that our findings of certain strains nearly exclusively in conservation areas (area 1 in particular) are "suggestive" of anthropogenic exposures (line 708), which doesn't exclude other possible sources. 6. L298-300: E. coli serovars (including O103) can often be associated with human, animal or avian sources. I agree with the authors that this serotype has caused human infections, but isn’t there a possibility that such strains can be associated naturally with the wild animals? We have revised the results and discussion to reflect the uncertainty of the pathogenicity of these serovars (lines 354-358; lines 614-615; lines 682-683). 7. Based on the statistical analysis, the chances of finding tet(B) were higher among swine manure isolates, those of blaTEM-1 and sul2I genes were higher among isolates from water. Are there any specific reasons for this association? Are certain antibiotics employed in these swine farms? Good questions. Unfortunately, we didn't have access to antimicrobial use data on the swine farms, and have suggested it for future work (lines 583-585). We have provided a possible explanation for the higher prevalence of blaTEM-1 and sul2 genes in water (lines 555-556). 8. In L491 it is said that tet(A) is not associated with any particular source overall. However, the following paragraph (L495-495) suggests that the tet(A) genes might have originated from the swine farms. Similarly, since tet(B) gene is more prevalent in water isolates, water was presumed to be the source of this gene in all other environments. These are contradictory. When this gene is uniformly found across different environments, how is its source and mode of dissemination predicted? Studies have shown tet genes in bacteria from pristine areas that were never exposed to antibiotics. Thank you for catching this error in over-interpretation of our analyses (we will need multivariable models to assess location type and source type in the same model). We inferred that primary sources of certain genes/plasmids would have a higher prevalence (this is an inference however). Uniform distributions don't tell us a whole lot, other than widespread dissemination, and that no particular source should necessarily be suspected as a primary source. We tried to simultaneously combine the broad scale analysis with the location type analysis, but this is over-interpretation, and beyond the ability of our hypothesis-generating study. We have removed the contradictory section, and revised the interpretation, and added another reference (lines 577-587). 9. In L589-591, it is stated that small animals are at higher risk of acquiring AMR E. coil through anthropogenic contamination. L80-81 suggest small mammals could be a potential source of AMR to humans and domestic animals. Although these statements are not mutually exclusive, we have added several phrases to capture both concepts throughout (line 70; line 682; lines 712-713). 10. Lines 532-533: “Resistant E. coli were significantly more likely to be detected on the paws of raccoons in conservation areas compared to swine farms”. Why is it so? The previous authors hypothesized that this was related to foraging behaviour by raccoons in dumpsters. We have added a line to convey this hypothesis (lines 638-639). 11. The manuscript emphasizes on pathogenic and resistant E. coli strains being found on the paws of raccoons. However, there is always a possibility of such strains being associated with the gastrointestinal tracts of healthy raccoons. A recent study [ Orden et al., 2020. Raccoons (Procyon lotor) in the Madrid region of Spain are carriers of antimicrobial-resistant Escherichia coli and enteropathogenic E. coli. Zoonoses Public Health. 2021; 68: 69– 78] have reported the presence of pathogenic and AMR E. coli in the feces of small mammals like raccoons and suggest these as the sources of such strains to humans. Certain serovars (e.g. O77, O25) were found both on raccoon paws and faeces in your study too. Thank you for pointing out this reference, it was missed. We have added these findings to the discussion (lines 682-685), and highlighted the zoonotic concern of potentially pathogenic E. coli strains isolated from raccoons (lines 712-713). Reviewer #2: The work presented in this article contributes to a comprehensive examination of the role of wildlife in the maintenance and dissemination of AMR determinants within the Grand River watershed. The work is particularly important to identify the circulation of antimicrobial resistance genes and the mobile genetic elements that facilitate their transmission among different sources including humans. Authors could successfully relate the association of some of the antimicrobial resistance determinants to a particular environment or location types. However, the authors have not discussed or analyzed the association of phenotypic resistance and the occurrence of corresponding drug resistance genes among different sources. We opted to perform only a preliminary scan of class-level sensitivity and specificity of in silico identification of AMR for our hypothesis-generating epidemiologic study. The aim of this work was focused on the epidemiology of those genes in different sources and location types, thus, we argue that a fine-scaled assessment of in silico methods was not necessary for our objective. The WGS data from the wildlife study have been deposited and the phenotypic data for those isolates was previously made available by Bondo et al. (see data URLs for those previous manuscripts), should readers want to assess gene level sensitivity and specificity for these isolates. There were many possible avenues for data analysis, and we decided to focus on areas that were supported by our expertise (i.e., epidemiology). In the interest of keeping our manuscript as streamlined as possible, and minimize the addition of further tables and analyses, we opted to keep our AMR phenotype-genotype assessment as it currently is, as a secondary objective to provide a course-grained validation of our statistical analyses. Comments 1. Authors have used a significant amount of data from their previous study, this causes repetition of data. While it's true that we have used the sequenced isolates from swine farms in this manuscript, we argue these manuscripts each have a different scope and different objectives regarding the epidemiology of AMR. The previous manuscript was focused on the epidemiology of AMR in E. coli (and in Salmonella) at the swine farm level, and the analyses addressed the following predictor variables: sampling year, site id, and source type. This manuscript builds on those previous analyses and examines location type and another source (water) from a broader geographic region. The previous manuscript is focused on a small-scale, local analysis, whereas the present manuscript is focused on broader scale analyses and epidemiological patterns which may be related to different types of environments (farm vs. conservation area), and sources (i.e., water). Combining this present manuscript with our previous analyses looking at both Salmonella and E. coli would have negatively affected interpretability, presentation of the data, discussion flow, and manuscript length. The end of the introduction has been re-worked to ensure it is clear why the present work was performed, and how it differs from the previous studies (lines 97-110). 2. Number of samples used from each source is not clearly mentioned in the methodology The number of isolates available for sequencing or that were previously sequenced have been added to the methods section (lines 158-161; lines 210-211). Submitted filename: Response to Reviewers.docx Click here for additional data file. 21 Mar 2022
PONE-D-21-40450R1
Using whole-genome sequence data to examine the epidemiology of antimicrobial resistance in Escherichia coli from wild meso-mammals and environmental sources on swine farms, conservation areas, and the Grand River watershed in southern Ontario
PLOS ONE Dear Dr. Vogt, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Some minor points to be addressed as pointed out by the reviewers. ============================== Please submit your revised manuscript by May 05 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Iddya Karunasagar Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): The revised version looks good, but there are some minor points to be addressed. Please see the reviewer comments. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: PONE-D-21-40450R1 The manuscript is adequately revised. A few minor points need attention. In the abstract, it is necessary to indicate that the soil isolates were 73 and dumpster isolates were 3 considering the huge difference in the number of isolates from these two sources. Line 77: Please delete “in” after “documented”. Line 78: Please insert a dot after [4, 17, 18]. And start with “However,” Impact of source type and location type An additional objective was to assess the validity of in silico identification of AMR genes, using phenotypic susceptibility test results as the gold standard. Does it mean the validity of the tool used? Does the specificity depend on the tool, targe genome or the sources? In your study, the test sensitivity for beta lactams was 90.2% and aminoglycosides, 81.8%. Is this the same as the positive predictive value?. Lines 161-181: The section under “Previous culture and susceptibility testing” . As I could understand, this data is from the previous study. In that case, the section can be merged with the previous section and reduced to few lines indicating only the antimicrobials tested. The methods, reference standards etc are available from the previous publication. Table 1: Please indicate bla genes in proper format. TEM is written as a subscript of bla and in normal font (TEM is not italicized). Reviewer #2: The authors have addressed all the reviewers comments and it can now be accepted for publication in the journal ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
22 Mar 2022 Thank you again for your helpful feedback and insights. The lines listed here correspond to the tracked changes version. Reviewer #1: PONE-D-21-40450R1 The manuscript is adequately revised. A few minor points need attention. In the abstract, it is necessary to indicate that the soil isolates were 73 and dumpster isolates were 3 considering the huge difference in the number of isolates from these two sources. We agree it is best to report these categories separately. The change has been made. Line 77: Please delete “in” after “documented”. Thank you for catching this error. Line 78: Please insert a dot after [4, 17, 18]. And start with “However,” The change has been made. An additional objective was to assess the validity of in silico identification of AMR genes, using phenotypic susceptibility test results as the gold standard. Does it mean the validity of the tool used? Does the specificity depend on the tool, targe genome or the sources? Interesting point. A line has been added to the discussion to elaborate on this (lines 607-611). The test performance depends largely on the AMR identification tool used, but other factors should also be considered (unlikely related to source, unless source impacts the quality of data). In your study, the test sensitivity for beta lactams was 90.2% and aminoglycosides, 81.8%. Is this the same as the positive predictive value?. The test sensitivity is a measure of the ability of the test to detect true positives (true positives that test positive/all true positives), whereas the positive predictive value is a measure of the probability of a test positive result being truly positive (true positives that test positive/all test positives). While positive predictive values have been used in this context (they are typically used in clinical medicine), I would prefer to avoid them since they are heavily influenced by the overall prevalence of the “disease” or AMR gene, in this case. Lines 161-181: The section under “Previous culture and susceptibility testing” . As I could understand, this data is from the previous study. In that case, the section can be merged with the previous section and reduced to few lines indicating only the antimicrobials tested. The methods, reference standards etc are available from the previous publication. This section has been shortened (lines 167-176), but important methodological information has been retained to ensure the reader can access the relevant information for the additional objective (validity of in silico AMR identification) within the same manuscript, without having to check the previous papers. Table 1: Please indicate bla genes in proper format. TEM is written as a subscript of bla and in normal font (TEM is not italicized). Thank you for pointing this out. The formatting has been corrected. Submitted filename: Responses to reviewers.docx Click here for additional data file. 29 Mar 2022 Using whole-genome sequence data to examine the epidemiology of antimicrobial resistance in Escherichia coli from wild meso-mammals and environmental sources on swine farms, conservation areas, and the Grand River watershed in southern Ontario PONE-D-21-40450R2 Dear Dr. Vogt, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Iddya Karunasagar Academic Editor PLOS ONE Additional Editor Comments (optional): All reviewer comments have been addressed Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No 31 Mar 2022 PONE-D-21-40450R2 Using whole-genome sequence data to examine the epidemiology of antimicrobial resistance in Escherichia coli from wild meso-mammals and environmental sources on swine farms, conservation areas, and the Grand River watershed in southern Ontario Dear Dr. Vogt: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Iddya Karunasagar Academic Editor PLOS ONE
  45 in total

1.  GrapeTree: visualization of core genomic relationships among 100,000 bacterial pathogens.

Authors:  Zhemin Zhou; Nabil-Fareed Alikhan; Martin J Sergeant; Nina Luhmann; Cátia Vaz; Alexandre P Francisco; João André Carriço; Mark Achtman
Journal:  Genome Res       Date:  2018-07-26       Impact factor: 9.043

2.  The colistin resistance mcr-1 gene is going wild.

Authors:  Apostolos Liakopoulos; Dik J Mevius; Björn Olsen; Jonas Bonnedahl
Journal:  J Antimicrob Chemother       Date:  2016-06-20       Impact factor: 5.790

3.  Antimicrobial resistance in generic Escherichia coli isolates from wild small mammals living in swine farm, residential, landfill, and natural environments in southern Ontario, Canada.

Authors:  Samantha E Allen; Patrick Boerlin; Nicol Janecko; John S Lumsden; Ian K Barker; David L Pearl; Richard J Reid-Smith; Claire Jardine
Journal:  Appl Environ Microbiol       Date:  2010-12-03       Impact factor: 4.792

4.  Rapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections.

Authors:  M Doumith; M Day; H Ciesielczuk; R Hope; A Underwood; R Reynolds; J Wain; D M Livermore; N Woodford
Journal:  J Clin Microbiol       Date:  2014-10-29       Impact factor: 5.948

5.  Antimicrobial resistance profiles in bacterial species isolated from fecal samples of free-ranging long-tailed macaques (Macaca fascicularis) living in Lopburi Old Town, Thailand.

Authors:  Duangjai Boonkusol; Suporn Thongyuan; Nantana Jangsuwan; Pornchai Sanyathitiseree
Journal:  Vet World       Date:  2020-07-22

6.  Clonal Diversity, Virulence Potential and Antimicrobial Resistance of Escherichia coli Causing Community Acquired Urinary Tract Infection in Switzerland.

Authors:  Magdalena T Nüesch-Inderbinen; Melinda Baschera; Katrin Zurfluh; Herbert Hächler; Hansjakob Nüesch; Roger Stephan
Journal:  Front Microbiol       Date:  2017-12-01       Impact factor: 5.640

7.  Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.

Authors:  Alessandro Cassini; Liselotte Diaz Högberg; Diamantis Plachouras; Annalisa Quattrocchi; Ana Hoxha; Gunnar Skov Simonsen; Mélanie Colomb-Cotinat; Mirjam E Kretzschmar; Brecht Devleesschauwer; Michele Cecchini; Driss Ait Ouakrim; Tiago Cravo Oliveira; Marc J Struelens; Carl Suetens; Dominique L Monnet
Journal:  Lancet Infect Dis       Date:  2018-11-05       Impact factor: 25.071

8.  Salmonellosis detection and evidence of antibiotic resistance in an urban raccoon population in a highly populated area, Costa Rica.

Authors:  Mario Baldi; Elías Barquero Calvo; Sabine E Hutter; Chris Walzer
Journal:  Zoonoses Public Health       Date:  2019-07-29       Impact factor: 2.702

9.  Distribution of ciprofloxacin-resistance genes among ST131 and non-ST131 clones of Escherichia coli isolates with ESBL phenotypes isolated from women with urinary tract infection.

Authors:  Masoumeh Rasoulinasab; Fereshteh Shahcheraghi; Mohammad Mehdi Feizabadi; Bahram Nikmanesh; Azade Hajihasani; Mohammad Mehdi Aslani
Journal:  Iran J Microbiol       Date:  2021-06

10.  Using whole-genome sequence data to examine the epidemiology of Salmonella, Escherichia coli and associated antimicrobial resistance in raccoons (Procyon lotor), swine manure pits, and soil samples on swine farms in southern Ontario, Canada.

Authors:  Nadine A Vogt; Benjamin M Hetman; David L Pearl; Adam A Vogt; Richard J Reid-Smith; E Jane Parmley; Nicol Janecko; Amrita Bharat; Michael R Mulvey; Nicole Ricker; Kristin J Bondo; Samantha E Allen; Claire M Jardine
Journal:  PLoS One       Date:  2021-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.